BlackRock, Inc.

Position in JNJ — Johnson & Johnson

CIK 2012383 New York, NY

Position in JNJ

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$52,159,962,852

+$8,952,702,007 QoQ

Shares Held

213,385,546

+2.2% QoQ

Ownership

8.86%

of shares outstanding

% of Portfolio

0.97%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 91.37196293510902.ToString("F0")% Shared 0.ToString("F0")% None 8.628037064890984.ToString("F0")%

Healthcare · as of Mar 31, 2026

BlackRock, Inc. holds $235,197,977,777 across 20 Drug Manufacturers - General names. JNJ ranks #2 (22.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	66,380,842	$61,055,107,035
2	JNJ	Johnson & Johnson This page	213,385,546	$52,159,962,852
3	ABBV	AbbVie Inc.	150,698,125	$32,775,335,197
4	MRK	Merck & Co., Inc.	225,830,330	$27,165,130,383
5	GILD	Gilead Sciences, Inc.	119,010,973	$16,586,559,291
6	AMGN	Amgen Inc	47,100,472	$16,572,301,062
7	PFE	Pfizer Inc	498,257,550	$13,991,071,992
8	BMY	Bristol Myers Squibb Co	171,682,888	$10,412,567,149

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$52,159,962,852	213,385,546	+2.2%	Shares	Sole	2026-05-13
2025-12-31	$43,207,260,845	208,781,159	+0.7%	Shares	Sole	2026-02-12
2025-09-30	$38,430,338,501	207,261,021	+1.7%	Shares	Sole	2025-11-12
2025-06-30	$31,137,977,818	203,849,282	+2.2%	Shares	Sole	2025-08-12
2025-03-31	$33,063,016,469	199,366,959	-1.0%	Shares	Sole	2025-05-02
2024-12-31	$29,116,575,837	201,331,599	+0.7%	Shares	Sole	2025-02-07
2024-09-30	$32,404,299,222	199,952,482	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.